Evidence map›Paper›PMID 27892798›Full record

ReviewPrion2016

Transmissibility of Gerstmann-Sträussler-Scheinker syndrome in rodent models: New insights into the molecular underpinnings of prion infectivity.

Romolo Nonno, Michele Angelo Di Bari, Umberto Agrimi, Laura Pirisinu

Open access · goldAbstract readReview
In one paragraph

Review in Prion, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Accumulation Area of a JapaneseJournal of clinical neurology (Seoul, Korea) · 2024
    Article
  5. Article
  6. The Prion Basis of Progressive Neurodegenerative Disorders.Interdisciplinary perspectives on infectious diseases · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Cofactor molecules: Essential partners for infectious prions.Progress in molecular biology and translational science · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Characterization of mutations inNeuropsychiatric disease and treatment · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Romolo Nonnoa Department of Veterinary Public Health and Food Safety , Istituto Superiore di Sanità , Rome , Italy.
Michele Angelo Di Baria Department of Veterinary Public Health and Food Safety , Istituto Superiore di Sanità , Rome , Italy.
Umberto Agrimia Department of Veterinary Public Health and Food Safety , Istituto Superiore di Sanità , Rome , Italy.
Laura Pirisinua Department of Veterinary Public Health and Food Safety , Istituto Superiore di Sanità , Rome , Italy.
Istituto Superiore di Sanità · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prion diseases, or transmissible spongiform encephalopathies, have revealed the bewildering phenomenon of transmissibility in neurodegenerative diseases. Hence, the experimental transmissibility of prion-like neurodegenerative diseases via template directed misfolding has become the focus of intense research. Gerstmann-Sträussler-Scheinker disease (GSS) is an inherited prion disease associated with mutations in the prion protein gene. However, with the exception of a few GSS cases with P102L mutation characterized by co-accumulation of protease-resistant PrP core (PrP

Indexed as

Disease Models, AnimalAnimalsGerstmann-Straussler-Scheinker DiseaseMiceMutationPrionsPrionsGerstmann-Straussler-Scheinker diseaseneurodegenerative diseasesprion infectivityprotein misfoldingPrPCPrPScstrain

Identifiers

PMID27892798
PMCPMC5161296
OpenAlexW2559743798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.